DXCM Financial Statements & Analysis
Complete financial statements for DXCM including income statement, balance sheet, and cash flow statement. Analyze DXCM's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
60
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
11.3% ↑
Net Income
6.4% ↑
Gross Margin
-4.3% ↓
Operating Margin
-9.8% ↓
Balance Sheet
Current Ratio
-48.4% ↓
Debt to Equity
-1.9% ↑
Asset Turnover
7.6% ↑
Cash Flow
Operating Cash Flow
32.2% ↑
Net Cash Flow
152.5% ↑
Free Cash Flow
23.2% ↑
Cash Flow to Debt
32.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 3.62B | 4.03B | 11.3% | |
| Gross Profit | 2.29B | 2.44B | 6.5% | |
| Operating Income | 597.70M | 600.00M | 0.4% | |
| Net Income | 541.50M | 576.20M | 6.4% | |
| EPS | 1.44 | 1.46 | 1.4% | |
| EBITDA | 916.70M | 945.70M | 3.2% | |
| Gross Margin | 63.19% | 60.46% | 4.3% | |
| Operating Margin | 16.50% | 14.88% | 9.8% | |
| Net Income Margin | 14.95% | 14.29% | 4.4% | |
| R&D Expenses | 505.80M | 552.40M | 9.2% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4.03B | 3.62B | 2.91B | 2.45B | 1.93B |
| Gross Profit | 2.44B | 2.29B | 1.88B | 1.68B | 1.28B |
| Operating Income | 600.00M | 597.70M | 391.20M | 265.80M | 299.50M |
| Net Income | 576.20M | 541.50M | 341.20M | 216.90M | 493.60M |
| EPS | 1.46 | 1.44 | 0.88 | 0.56 | 1.31 |
| EBITDA | 945.70M | 916.70M | 565.30M | 377.50M | 376.80M |
| Gross Margin | 60.46% | 63.19% | 64.72% | 68.63% | 66.44% |
| Operating Margin | 14.88% | 16.50% | 13.44% | 10.86% | 15.54% |
| Net Income Margin | 14.29% | 14.95% | 11.73% | 8.86% | 25.62% |
| R&D Expenses | 552.40M | 505.80M | 484.20M | 604.20M | 359.90M |